93 related articles for article (PubMed ID: 9414411)
1. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
[TBL] [Abstract][Full Text] [Related]
2. [T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions].
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1622-5. PubMed ID: 7574776
[TBL] [Abstract][Full Text] [Related]
3. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients.
Miyahara E; Yamaguchi Y; Minami K; Hihara J; Noma K; Toge T; Takafuta T; Fujimura K
Anticancer Res; 1999; 19(3A):2057-66. PubMed ID: 10470148
[TBL] [Abstract][Full Text] [Related]
6. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
7. Usage of T cell receptor (TCR) V beta gene in ulcerative colitis.
Shigematsu M; Masuda H
J Clin Lab Immunol; 1996; 48(5):177-86. PubMed ID: 9394241
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
Uchida A; Micksche M; Hoshino T
Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
[TBL] [Abstract][Full Text] [Related]
9. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
11. [Restricted usage of repertoire of T-cell receptor V beta in Chinese asthmatics].
Guo X; Li W; Deng W; Ni P; Yu S; Li Y; Zhang H
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):78-80. PubMed ID: 11953102
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
Kan N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
[TBL] [Abstract][Full Text] [Related]
13. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T
Anticancer Res; 1999; 19(2A):1077-84. PubMed ID: 10368657
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
16. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
17. Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans.
Hayashi K; Yonamine K; Masuko-Hongo K; Iida T; Yamamoto K; Nishioka K; Kato T
Gynecol Oncol; 1999 Jul; 74(1):86-92. PubMed ID: 10385556
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
19. [Intratumoral administration of OK432 in rats with liver tumor].
Ishimaru M
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
[TBL] [Abstract][Full Text] [Related]
20. Analysis of T cell receptors reactive with squamous cell carcinoma antigen SART-1 presented by the HLA-A24 molecule.
Shimizu K; Yamaguchi Y; Ohta K; Miyahara E; Toge T
Oncol Rep; 2002; 9(3):599-605. PubMed ID: 11956635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]